Angiopoietin-1 upregulates de novo expression of Il-1β and Il1-Ra, and the exclusive release of Il1-Ra from human neutrophils

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Haddad, Lydia E ^a,b   Sirois, Martin G ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; IL 1RA GENE; INTERLEUKIN 1ALPHA GENE; INTERLEUKIN 1BETA GENE; NEUTROPHIL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANGIOPOIETIN-1; CHEMOTAXIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POTASSIUM; RNA, MESSENGER;

EID: 84895726403     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088980     Document Type: Article

References (59)

1. Arroyo AG, Iruela-Arispe ML (2010) Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc Res 86: 226-235.
2. Ahmad S, Cudmore MJ, Wang K, Hewett P, Potluri R, et al. (2010) Angiopoietin-1 induces migration of monocytes in a tie-2 and integrinin-dependent manner. Hypertension 56: 477-483.
3. Feistritzer C, Mosheimer BA, Sturn DH, Bijuklic K, Patsch JR, et al. (2004) Expression and function of the angiopoietin receptor Tie-2 in human eosinophils. J Allergy Clin Immunol 114: 1077-1084. (Pubitemid 39469147)
4. Lemieux C, Maliba R, Favier J, Theoret JF, Merhi Y, et al. (2005) Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 105: 1523-1530. (Pubitemid 40223669)
5. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, et al. (2000) Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87: 603-607.
6. Pizurki L, Zhou Z, Glynos K, Roussos C, Papapetropoulos A (2003) Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol 139: 329-336. (Pubitemid 36760365)
7. Oubaha M, Gratton JP (2009) Phosphorylation of endothelial nitric oxide synthase by atypical PKC zeta contributes to angiopoietin-1-dependent inhibition of VEGF-induced endothelial permeability in vitro. Blood 114: 3343-3351.
8. Kim I, Oh JL, Ryu YS, So JN, Sessa WC, et al. (2002) Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells. FASEB J 16: 126-128.
9. Kim I, Moon SO, Park SK, Chae SW, Koh GY (2001) Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 89: 477-479. (Pubitemid 34132640)
10. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, et al. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463. (Pubitemid 30208166)
11. Maliba R, Brkovic A, Neagoe PE, Villeneuve LR, Sirois MG (2008) Angiopoietin-mediated endothelial P-selectin translocation: cell signaling mechanisms. J Leukoc Biol 83: 352-360. (Pubitemid 351225616)
12. Neagoe PE, Dumas E, Hajjar F, Sirois MG (2012) Angiopoietin-1 but not angiopoietin-2 induces IL-8 synthesis and release by human neutrophils. J Cell Physiol 227: 3099-3110.
13. Dumas E, Martel C, Neagoe PE, Bonnefoy A, Sirois MG (2012) Angiopoietin-1 but not angiopoietin-2 promotes neutrophil viability: Role of interleukin-8 and platelet-activating factor. Biochim Biophys Acta 1823: 358-367.
14. Brkovic A, Pelletier M, Girard D, Sirois MG (2007) Angiopoietin chemotactic activities on neutrophils are regulated by PI-3K activation. J Leukoc Biol 81: 1093-1101. (Pubitemid 46495658)
15. Sturn DH, Feistritzer C, Mosheimer BA, Djanani A, Bijuklic K, et al. (2005) Angiopoietin affects neutrophil migration. Microcirculation 12: 393-403. (Pubitemid 41122464)
16. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, et al. (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12: 235-239. (Pubitemid 43214752)
17. Cassatella MA (1995) The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16: 21-26.
18. Ely EW, Seeds MC, Chilton FH, Bass DA (1995) Neutrophil release of arachidonic acid, oxidants, and proteinases: causally related or independent. Biochim Biophys Acta 1258: 135-144.
19. Jablonska E, Kiluk M, Markiewicz W, Piotrowski L, Grabowska Z, et al. (2001) TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients. Arch Immunol Ther Exp (Warsz) 49: 63-69. (Pubitemid 33611199)
20. Riedemann NC, Guo RF, Hollmann TJ, Gao H, Neff TA, et al. (2004) Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 18: 370-372.
21. Kuhns DB, Young HA, Gallin EK, Gallin JI (1998) Ca2+-dependent production and release of IL-8 in human neutrophils. J Immunol 161: 4332-4339. (Pubitemid 28469018)
22. Lapinet JA, Scapini P, Calzetti F, Perez O, Cassatella MA (2000) Gene expression and production of tumor necrosis factor alpha, interleukin-1beta (IL-1beta), IL-8, macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, and gamma interferon-inducible protein 10 by human neutrophils stimulated with group B meningococcal outer membrane vesicles. Infect Immun 68: 6917-6923. (Pubitemid 32463403)
23. Xing L, Remick DG (2003) Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils. Shock 20: 10-16.
24. Theoret JF, Bienvenu JG, Kumar A, Merhi Y (2001) P-selectin antagonism with recombinant p-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces. J Pharmacol Exp Ther 298: 658-664. (Pubitemid 32673417)
25. Rollin S, Lemieux C, Maliba R, Favier J, Villeneuve LR, et al. (2004) VEGFmediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesis. Blood 103: 3789-3797. (Pubitemid 38596297)
26. Neagoe PE, Brkovic A, Hajjar F, Sirois MG (2009) Expression and release of angiopoietin-1 from human neutrophils: intracellular mechanisms. Growth Factors 27: 335-344.
27. Perregaux D, Barberia J, Lanzetti AJ, Geoghegan KF, Carty TJ, et al. (1992) IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin. J Immunol 149: 1294-1303.
28. Perregaux D, Gabel CA (1994) Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 269: 15195-15203.
29. Arend WP, Palmer G, Gabay C (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223: 20-38. (Pubitemid 351986169)
30. Arend WP, Smith MF Jr, Janson RW, Joslin FG (1991) IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently. J Immunol 147: 1530-1536.
31. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, et al. (2006) The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176: 3877-3883. (Pubitemid 44264361)
32. Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, et al. (2010) IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog 6: e1000661.
33. Hogquist KA, Unanue ER, Chaplin DD (1991) Release of IL-1 from mononuclear phagocytes. J Immunol 147: 2181-2186.
34. Chin J, Kostura MJ (1993) Dissociation of IL-1 beta synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products. J Immunol 151: 5574-5585.
35. Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, et al. (2010) Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol 184: 3326-3330.
36. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, et al. (2007) NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130: 918-931. (Pubitemid 47332565)
37. Guma M, Ronacher L, Liu-Bryan R, Takai S, Karin M, et al. (2009) Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum 60: 3642-3650.
38. Young RE, Thompson RD, Larbi KY, La M, Roberts CE, et al. (2004) Neutrophil elastase (NE)-deficient mice demonstrate a nonredundant role for NE in neutrophil migration, generation of proinflammatory mediators, and phagocytosis in response to zymosan particles in vivo. J Immunol 172: 4493-4502. (Pubitemid 38375266)
39. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, et al. (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276: 125-132. (Pubitemid 32050297)
40. Perregaux DG, Laliberte RE, Gabel CA (1996) Human monocyte interleukin-1beta posttranslational processing. Evidence of a volume-regulated response. J Biol Chem 271: 29830-29838. (Pubitemid 26389614)
41. Kim I, Kim JH, Moon SO, Kwak HJ, Kim NG, et al. (2000) Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 39-kinase/Akt signal transduction pathway. Oncogene 19: 4549-4552.
42. Harfouche R, Gratton JP, Yancopoulos GD, Noseda M, Karsan A, et al. (2003) Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases. Faseb J 17: 1523-1525.
43. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, et al. (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 39-Kinase/Akt signal transduction pathway. Circ Res 86: 24-29. (Pubitemid 30044164)
44. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, et al. (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233.
45. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632. (Pubitemid 28334795)
46. Sun J, Ramnath RD, Tamizhselvi R, Bhatia M (2009) Role of protein kinase C and phosphoinositide 3-kinase-Akt in substance P-induced proinflammatory pathways in mouse macrophages. FASEB J 23: 997-1010.
47. Fagiani E, Christofori G (2013) Angiopoietins in angiogenesis. Cancer Lett 328: 18-26.
48. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, et al. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J 21: 325-332. (Pubitemid 46213480)
49. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519-550.
50. Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117: 3720-3732.
51. Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, et al. (2009) Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113: 2324-2335.
52. Brough D, Le Feuvre RA, Iwakura Y, Rothwell NJ (2002) Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1- independent mechanism. Mol Cell Neurosci 19: 272-280. (Pubitemid 34211906)
53. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746.
54. Lee JC, Young PR (1996) Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol 59: 152-157. (Pubitemid 26098701)
55. Carter AB, Monick MM, Hunninghake GW (1999) Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 20: 751-758. (Pubitemid 129495663)
56. Baldassare JJ, Bi Y, Bellone CJ (1999) The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J Immunol 162: 5367-5373. (Pubitemid 29307144)
57. Alvarez ME, Fuxman Bass JI, Geffner JR, Calotti PX, Costas M, et al. (2006) Neutrophil signaling pathways activated by bacterial DNA stimulation. J Immunol 177: 4037-4046. (Pubitemid 44359937)
58. Lu P, Nakamoto Y, Nemoto-Sasaki Y, Fujii C, Wang H, et al. (2003) Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. Am J Pathol 162: 1249-1258. (Pubitemid 36350669)
59. Langereis JD, Oudijk EJ, Schweizer RC, Lammers JW, Koenderman L, et al. (2011) Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1beta synthesis by human neutrophils. Eur Respir J 37: 406-415.